Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Chang

Showing results (251-260 of 386) with videos related to

Pageof 39
Sort By:
NPJ Digital Medicine|August 7, 2025
Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRINate Tran, Tracy L Luks, Yan Li, et al.
Neuroimage. Clinical|August 23, 2023
Multi-parametric hyperpolarized <sup>13</sup>C/<sup>1</sup>H imaging reveals Warburg-related metabolic dysfunction and associated regional heterogeneity in high-grade human gliomasAdam W Autry, Sana Vaziri, Marisa LaFontaine, et al.
Cell Reports|March 29, 2018
Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma ProliferationHarish N Vasudevan, Steve E Braunstein, Joanna J Phillips, et al.
Neurosurgery|January 4, 2022
Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type GlioblastomaAlexander A Aabedi, Jacob S Young, Yalan Zhang, et al.
Journal of the American College of Radiology : JACR|May 23, 2025
ACR Appropriateness Criteria® Brain Tumors, Jana Ivanidze, Robert Y Shih, et al.
Neuro-Oncology Practice|March 9, 2026
Tele-cognitive rehabilitation for adult lower-grade glioma: An interim prospective pilot feasibility studyChristina Weyer-Jamora, Melissa S Brie, Paige M Bracci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2019
Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons GuidelinesSusan M Chang, Hans Messersmith, Manmeet Ahluwalia, et al.
Neuro-Oncology|September 8, 2011
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcomaNicholas Butowski, Susan M Chang, Kathleen R Lamborn, et al.
Neuro-Oncology|February 11, 2004
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, W K A Yung, Kurt A Jaeckle, et al.
Neuro-Oncology|March 19, 2019
Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelinesSusan M Chang, Hans Messersmith, Manmeet Ahluwalia, et al.
Pageof 39

Showing results (251-260 of 386) with videos related to

Sort By:
Pageof 39
NPJ Digital Medicine|August 7, 2025
Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRINate Tran, Tracy L Luks, Yan Li, et al.
Neuroimage. Clinical|August 23, 2023
Multi-parametric hyperpolarized <sup>13</sup>C/<sup>1</sup>H imaging reveals Warburg-related metabolic dysfunction and associated regional heterogeneity in high-grade human gliomasAdam W Autry, Sana Vaziri, Marisa LaFontaine, et al.
Cell Reports|March 29, 2018
Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma ProliferationHarish N Vasudevan, Steve E Braunstein, Joanna J Phillips, et al.
Neurosurgery|January 4, 2022
Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type GlioblastomaAlexander A Aabedi, Jacob S Young, Yalan Zhang, et al.
Journal of the American College of Radiology : JACR|May 23, 2025
ACR Appropriateness Criteria® Brain Tumors, Jana Ivanidze, Robert Y Shih, et al.
Neuro-Oncology Practice|March 9, 2026
Tele-cognitive rehabilitation for adult lower-grade glioma: An interim prospective pilot feasibility studyChristina Weyer-Jamora, Melissa S Brie, Paige M Bracci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2019
Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons GuidelinesSusan M Chang, Hans Messersmith, Manmeet Ahluwalia, et al.
Neuro-Oncology|September 8, 2011
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcomaNicholas Butowski, Susan M Chang, Kathleen R Lamborn, et al.
Neuro-Oncology|February 11, 2004
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, W K A Yung, Kurt A Jaeckle, et al.
Neuro-Oncology|March 19, 2019
Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelinesSusan M Chang, Hans Messersmith, Manmeet Ahluwalia, et al.
Pageof 39